Skip to Main Content

Newsletter sign up

Each month brings new progress in chordoma research, and a variety of opportunities to connect with others and participate in our shared mission. Our newsletter will keep you up to date. Sign up here, and check out past editions below.

Please select your language.
Contact Information

















The Chordoma Foundation values your privacy and will not sell or share your information with any other organizations.

July 2024


New clinical trial results. Biobank needs. NCI findings.

Read about promising trial results from two clinical trials, the need for tumor samples to advance research, new genetic findings from an NCI study, and more.

View the newsletter

May 2024


Quality-of-life paper, immunotherapy strides, and CF Labs on X.

Read about new research on quality-of-life for chordoma survivors, our upcoming Chordoma Community Day in Chicago, and more.

View the newsletter

March 2024


In memory of Mac. Immunotherapy progress. Open science.

Read about Mac Sinise's legacy, potential new treatment strategies, our upcoming regional meet-ups and more.

View the newsletter

October 2023


Clinical trial update and national attention to our lab

Learn about the ongoing cetuximab trial, how to help patients in need, and more.

View the newsletter

August 2023


Owning our destiny

Read our latest annual report and learn about upcoming opportunities to learn and engage.

View the newsletter

June 2023


First evidence that targeting brachyury inhibits chordoma tumors in mice

Plus a recap of a pediatric chordoma clinic and more.

View the newsletter

April 2023


Three new potential therapeutic approaches identified for patients

Read about new potential treatments, upcoming events, a way to propel our mission, and more.

View the newsletter

February 2023


Two invitations for patients and caregivers

Our patient services team shares two opportunities to engage with the Chordoma Foundation and one of our partners.

View the newsletter

December 2022


Illuminating the path to better treatments

Read about chordoma clinical trial responses, guiding new treatment development, a pediatric clinic, and more.

View the newsletter